Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer

Study ID
NCT01910610

Study type
Interventional

Study phase
Phase 3

Study status
Active, not recruiting

Trial Acronym

STRATEGIC-1

Trial Summary

STRATEGIC-1 is a study designed to determine the best sequence of therapy in patients with metastatic colorectal cancer.

More informations

Trial Starting Date

Oct 30,2013

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

464